Pregnant women with erythema migrans and isolation of borreliae from blood: course and outcome after treatment with ceftriaxone.
The course and outcome in 7 pregnant European women with erythema migrans and borreliae isolated from blood, treated with intravenous ceftriaxone for 14 days, were uneventful, and the outcome of their pregnancies was good. Spirochetemia was not associated with constitutional symptoms.